Exchange Traded Concepts’s Acrivon Therapeutics ACRV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-23,161
| Closed | -$47K | – | 1391 |
|
|
2025
Q1 | $47K | Buy |
23,161
+2,813
| +14% | +$5.71K | ﹤0.01% | 1228 |
|
|
2024
Q4 | $122K | Hold |
20,348
| – | – | ﹤0.01% | 1105 |
|
|
2024
Q3 | $142K | Sell |
20,348
-22,516
| -53% | -$158K | ﹤0.01% | 1077 |
|
|
2024
Q2 | $249K | Sell |
42,864
-13,336
| -24% | -$77.3K | 0.01% | 844 |
|
|
2024
Q1 | $402K | Buy |
56,200
+42,911
| +323% | +$307K | 0.01% | 678 |
|
|
2023
Q4 | $65.4K | Buy |
13,289
+3,370
| +34% | +$16.6K | ﹤0.01% | 923 |
|
|
2023
Q3 | $94.8K | Sell |
9,919
-1,790
| -15% | -$17.1K | ﹤0.01% | 916 |
|
|
2023
Q2 | $152K | Buy |
+11,709
| New | +$152K | ﹤0.01% | 836 |
|